Jeraygo (aprocitentan)
Additional monitoring
- Region
- 🇪🇺 EU
- Active substance
- aprocitentan
- Company
- Idorsia Pharmaceuticals Deutschland GmbH
- Status
- Authorised
- Therapeutic area
- Hypertension
- CHMP opinion
- Fri 26 Apr 2024
- Designations
- Additional monitoring
- Application
- EMEA/H/C/006080
- ATC
- C02KN01
- Official record
- www.ema.europa.eu
Indication
Treatment of resistant hypertension
Regulatory milestones
No milestones recorded in the last year.
Follow Jeraygo
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.